Vazdar, L., Gabrić, I. D., Kruljac, I., Pintarić, H., Šeparović, R., Kirigin Biloš, L. S., . . . Štefanović, M. (2021). Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer. Sci Rep.
Chicago Style aipamenaVazdar, Ljubica, Ivo Darko Gabrić, Ivan Kruljac, Hrvoje Pintarić, Robert Šeparović, Lora Stanka Kirigin Biloš, Mirjana Pavlović, Ana Tečić Vuger, and Mario Štefanović. "Influence of Ile655Val Polymorphism On Trastuzumab-induced Cardiotoxicity in Early-stage HER2 Positive Breast Cancer." Sci Rep 2021.
MLA aipamenaVazdar, Ljubica, et al. "Influence of Ile655Val Polymorphism On Trastuzumab-induced Cardiotoxicity in Early-stage HER2 Positive Breast Cancer." Sci Rep 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.